17 alpha-hydroxyprogesterone caproate has been researched along with Allodynia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coronel, MF; Gonzalez, SL; Miguel, CA; Raggio, MC; Villar, MJ | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Allodynia
| Article | Year |
|---|---|
Anti-allodynic and anti-inflammatory effects of 17α-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Antineoplastic Agents; Behavior, Animal; Disease Models, Animal; Hyperalgesia; Male; Neuralgia; Oxaliplatin; Peripheral Nervous System Diseases; Progestins; Rats; Rats, Sprague-Dawley | 2019 |